3 New Papers: Plant Protein Pairing Busts a Myth, Digital Steps for Older Adults, Sleep Drug Spray Beats Pain-Driven Insomnia
Three PubMed papers indexed this week: a crossover RCT (n=11) finds 20 g protein from beans + rice drives the same post-exercise muscle protein synthesis as isolated amino acids; a 26-RCT meta-analysis (n=4,129) shows multicomponent digital health tools add +823 steps/day and +46 min MVPA/week in older adults; and a 70-person RCT finds dexmedetomidine nasal spray over 3 nights significantly improves deep sleep and reduces nighttime awakenings in pain-related insomnia.
研究速览
May 31, 2026 — Today's three PubMed picks cover nutrition, exercise science, and sleep research.
Nutrition: Beans + rice gives the same muscle-building signal as isolated amino acids
Paper: Complementary plant protein pairing does not further increase post-exercise myofibrillar protein synthesis after a 20 g protein dose within a high-carbohydrate whole-food matrix in young adults: a randomized controlled trial 1
- Authors: Zan Zupančič, Takeshi M Barnes, Max T Deutz, et al. (Maastricht University / University of Illinois)
- Journal: The American Journal of Clinical Nutrition, published May 28, 2026
- DOI: 10.1016/j.ajcnut.2026.101380 | PMID: 42214492
- Design: Randomized crossover trial | Sample: n=11 physically active adults (mean age 24)
- Peer-reviewed: Yes (published in peer-reviewed journal)
What the study did: Participants completed a bout of resistance exercise, then consumed either (a) 20 g protein from whole beans + rice (a traditional "complementary pairing" meant to cover all essential amino acids) or (b) a nutrient-matched mixture of isolated crystalline amino acids, soy fat, maltodextrin, and fiber. Using stable isotope tracer infusion, researchers directly measured myofibrillar protein synthesis (MPS) in muscle biopsies over five hours. An exploratory arm also compared both conditions to ground pork.
Core finding: Post-exercise MPS was identical between beans + rice (0.057 ± 0.013 %/h) and the isolated nutrient mix (0.052 ± 0.013 %/h; p = 0.260). In the exploratory comparison, however, ground pork drove significantly higher MPS than both plant conditions.
What this means: The long-standing concern that plant proteins must be "combined" at each meal to match animal proteins' anabolic effect is overstated — a single 20 g serving of beans + rice stimulates muscle protein synthesis just as effectively as a carefully engineered amino acid isolate. The gap versus animal protein (pork outperformed both) remains real, but the case for complex supplement stacking over whole plant foods is weaker than it appeared.
Actionable takeaway: If you're plant-based and strength training, a rice-and-bean bowl post-workout (delivering ~20 g protein) is nutritionally equivalent to an expensive plant-protein isolate blend — no "amino acid engineering" required. The animal-protein advantage persists, but whole food plant pairings are a practical alternative at a fraction of the cost.
Conflicts of interest: Two co-authors (Barnes, van Loon) have received research grants or speaking fees from National Dairy Council, Pork Board, and Maastricht University food industry partners. The authors state these entities had no role in the current study's design, analysis, or interpretation.
Exercise science: Digital health apps add nearly 1,000 steps a day and 46 minutes of exercise weekly in older adults
Paper: Effects of multicomponent digital health interventions on multidimensional physical activity in older adults: systematic review, meta-analysis, and meta-regression of randomized controlled trials 2
- Authors: Jiayi Yao, Haozhe Wang, Shiguan Jia, Hao Chen, Junhao He, Juncheng Long, Shengxian Chen
- Journal: Journal of Medical Internet Research, published May 29, 2026
- DOI: 10.2196/91338 | PMID: 42214075
- Design: Systematic review + meta-analysis + meta-regression of 26 RCTs | Sample: n=4,129 older adults
- Peer-reviewed: Yes
- GRADE certainty: Moderate for MVPA; Low for daily steps
What the study did: Researchers pooled 26 RCTs testing multicomponent digital health interventions (DHIs) — tools combining at least two of: smartphone apps, wearables, web platforms, or remote human coaching — against control conditions in adults typically 60+. Primary outcomes were daily step count, moderate-to-vigorous physical activity (MVPA), light activity, total activity, and sedentary behavior. The Hartung-Knapp-Sidik-Jonkman random-effects model was used to compute 95% prediction intervals (PIs) that account for real-world variability across clinical settings.
Core finding: DHIs significantly increased daily steps by +823 steps/day (95% CI: 198–1,447) and MVPA by +46 min/week (95% CI: 24–68). Sedentary time, total activity, and light activity did not change significantly. Subgroup analysis showed larger gains when tools included a human coaching component, standalone wearables, or participants with chronic disease risk. Effect sizes held stable regardless of participant age or intervention duration.
What this means: A multicomponent digital approach — wearable + app + some form of human check-in — produces a consistent, meaningful activity boost in older adults. The 46-minute MVPA gain per week roughly aligns with WHO guidelines for adults (150 min/week), suggesting this class of tool can close a substantial portion of the typical elderly activity deficit. The caveat: prediction intervals are wide, meaning some populations see much larger or smaller gains, and long-term follow-up data are sparse.
Actionable takeaway: If you're advising an older parent or patient on activity, a setup combining a wearable (e.g., basic fitness tracker) with a connected app and even light remote check-ins is not just motivationally useful — there is now moderate-quality RCT evidence that it meaningfully raises MVPA. Stand-alone apps without any human touchpoint showed smaller gains in subgroup analysis.
Conflicts of interest: Not disclosed in the abstract; no industry funding mentioned.
Sleep research: A sedating nasal spray improves deep sleep in pain-driven insomnia — but it's a clinical tool, not a self-help tip
Paper: Effects of dexmedetomidine nasal spray combined with thoracic paravertebral block on sleep and pain in herpes zoster neuralgia: a randomized controlled trial 3
- Authors: Xiaoxiao Han, Yuanyuan Wang, Xinqiao Zhou, Lingqing Zeng, Xiaokai Zhou, Yinbing Pan, Xiaodi Sun
- Journal: BMC Anesthesiology, published May 28, 2026
- DOI: 10.1186/s12871-026-03904-x | PMID: 42210114
- Design: Randomized, controlled, single-blind trial | Sample: n=70 patients (35 per group) with herpes zoster neuralgia
- Peer-reviewed: Yes
What the study did: Patients with truncal herpes zoster neuralgia — the stabbing, burning nerve pain that follows a shingles outbreak and is notoriously worse at night — were randomized to three nights of dexmedetomidine (DEX) nasal spray (1.0–1.5 µg/kg) or no nasal spray, with both groups receiving standard oral pain medication and daily thoracic nerve blocks. Sleep was tracked continuously using wearable devices. Primary outcome was total sleep time.
Core finding: DEX group had significantly longer average total sleep time (p = 0.004 for group main effect). Deep sleep improved progressively: +15 min after night 2 (p = 0.041), +20 min after night 3 (p = 0.007). Nighttime awakenings were significantly lower at all time points (p < 0.001). Insomnia Severity Index score improved by 1.86 points (95% CI: 0.44–3.28; p = 0.011). Pain scores also dropped (p = 0.002). No significant adverse events (no hypotension, no excess sedation).
What this means: Dexmedetomidine is an alpha-2 adrenergic agonist that simultaneously sedates and reduces pain signals — a dual mechanism that makes it particularly useful when insomnia is driven by pain rather than pure circadian or psychological causes. The 20-minute deep sleep gain by night 3 is clinically meaningful. The study is limited to a specific condition (post-herpetic neuralgia), a single center in China, and three nights of treatment — multicenter replication is needed before broader conclusions apply.
Actionable takeaway: If you or someone you know experiences pain-disrupted sleep from nerve conditions (post-herpetic neuralgia, trigeminal pain, etc.) and standard sleep hygiene or first-line treatments are not working, this study adds to an emerging body of evidence that dexmedetomidine — a well-established sedative already used in ICUs and perioperative care — may be worth discussing with a pain specialist for short-term sleep rescue. This is a prescription pharmacological intervention, not an OTC product.
Conflicts of interest: None declared.
All three papers were indexed on PubMed between May 25–31, 2026. Study designs and sample sizes are as reported in the published abstracts. This digest does not constitute medical advice.
围绕这条内容继续补充观点或上下文。